Cafepharma Today

June 26 2025 - Altimmune's stock sinks on mixed phase 2 MASH results for GLP-1 drug
Altimmune's stock sinks on mixed phase 2 MASH results for GLP-1 drug
Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes
Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy
RFK Jr.'s vaccine advisors recommend RSV antibodies for infants
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ImClone Systems updates Erbitux study with missed secondary goal data, affirms main study goal
Yahoo/AP
Tuesday, September 16, 2008 - 9:57am
tags:
Amgen Stays a Long-Term Hold
Yahoo/Zacks.com
Tuesday, September 16, 2008 - 9:43am
tags:
Pfizer plans on switching remaining Exubera patients to developing MannKind treatment
Yahoo/AP
Tuesday, September 16, 2008 - 9:40am
tags:
Eli Lilly downgraded to 'Underweight' on key patent expirations and early-stage pipeline
Yahoo/AP
Tuesday, September 16, 2008 - 9:39am
tags:
Ahead of the Bell: Generic Drug Developers
CNN Money
Tuesday, September 16, 2008 - 8:27am
tags:
Pharmacopeia and GlaxoSmithKline Collaboration Identifies Sixth Lead Compound
Yahoo
Tuesday, September 16, 2008 - 8:25am
tags:
Bristol-Myers’s Love for Imclone Only Goes So Far
WSJ Online
Tuesday, September 16, 2008 - 8:24am
tags:
MannKind's inhaled insulin meets treatment goal for Type 1 diabetes in late-stage study
Yahoo/AP
Tuesday, September 16, 2008 - 8:23am
tags:
MannKind shares rise ahead of clinical trial data
Yahoo/AP
Tuesday, September 16, 2008 - 8:22am
tags:
Bayer Rises to Seven-Month High on Speculation Pfizer Will Bid
Bloomberg
Tuesday, September 16, 2008 - 8:02am
tags:
Bayer’s Wenning: Not Vulnerable To A Takeover
Pharmalot
Tuesday, September 16, 2008 - 8:01am
tags:
Glaxo May Have Abused EU Drug Trade Rules, Court Says
Bloomberg
Tuesday, September 16, 2008 - 7:54am
tags:
Bristol-Myers could walk away from ImClone: CFO
Yahoo/Reuters
Tuesday, September 16, 2008 - 7:53am
tags:
Roche says Erbitux data confirms Avastin has edge
Reuters
Tuesday, September 16, 2008 - 7:51am
tags:
Bristol-Myers Squibb files for IPO to spin off Mead Johnson; plans to hold 80 pct of shares
Yahoo/AP
Tuesday, September 16, 2008 - 7:51am
tags:
Wyeth drug misses mark, Amgen's builds bones
Yahoo/AP
Tuesday, September 16, 2008 - 7:46am
tags:
Label Expansion Likely Of Little Benefit For Gardasil
Forbes
Tuesday, September 16, 2008 - 7:45am
tags:
Amgen sells 2 biotech drugs, licenses third
Yahoo/AP
Tuesday, September 16, 2008 - 7:44am
tags:
AstraZeneca, Targacept say results of Alzheimer's drug study are inconclusive
Yahoo/AP
Tuesday, September 16, 2008 - 7:43am
tags:
Invitrogen, Biocare to Market FDA Approved Breast Cancer Test
Yahoo
Tuesday, September 16, 2008 - 7:42am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.